Levamisole monotherapy for oral lichen planus

Annals of Dermatology

Volumn 21, Issue 3, 2009, Pages 250-254

  Won, Tai Hyok ^a   Park, Se Young ^a   Kim, Bo Suk ^a   Seo, Phil Seung ^a   Park, Seok Don ^b  

^a Wonkwang University   (South Korea)

^b Wonkwang University School of Medicine   (South Korea)

Author keywords

Levamisole; Oral lichen planus (OLP)

Indexed keywords

EID: 70350330469     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2009.21.3.250     Document Type: Article

References (34)

1. Wilson E. On lichen planus. J Cutan Med Dis Skin 1869; 3: 117-132.
2. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 2002;46:207-214
3. Carrozzo M, Gandolfo S. The management of oral lichen planus. Oral Dis 1999;5:196-205.
4. Eisen D, Griffiths CE, Ellis CN, Nickoloff BJ, Voorhees JJ. Cyclosporin wash for oral lichen planus. Lancet 1990;335: 535-536.
5. Eisen D, Ellis CN, Duell EA, Griffiths CE, Voorhees JJ. Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis. N Engl J Med 1990;323:290-294.
6. Eisen D, Elłis CN. Topical cyclosporine for oral mucosal disorders. J Am Acad Dermatol 1990;23:1259-1263.
7. Aufdemorte TB, De Villez RL, Gieseker DR. Griseofulvin in the treatment of three cases of oral erosive lichen planus. Oral Surg Oral Med Oral Pathol 1983;55:459-462.
8. Massa MC, Rogers RS 3rd. Griseofulvin therapy of lichen planus. Acta Derm Venereol 1981; 61: 547-550.
9. Sehgal VN, Abraham GJ, Malik GB. Griseofulvin therapy in lichen planus. A double-blind controlled trial. Br J Dermatol 1972;87:383-385.
10. Kaliakatsou F, Hodgson TA, Lewsey JD, Hegarty AM, Murphy AG, Porter SR. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 2002;46:35-41.
11. Thomson MA, Hamburger J, Stewart DG, Lewis HM. Treatment of erosive oral lichen planus with topical tacrolimus. J Dermatolog Treat 2004;15:308-314.
12. Byrd JA, Davis MD, Bruce AJ, Drage LA, Rogers RS 3rd. Response of oral lichen planus to topical tacrolimus in 37 patients. Arch Dermatol 2004;140: 1508-1512.
13. Sloberg K, Hersle K, Mobacken H, Thilander H. Topical tretinoin therapy and oral lichen planus. Arch Dermatol 1979;115:716-718.
14. Lu SY, Chen WJ, Eng HL. Dramatic response to levamisole and low-dose prednisolone in 23 patients with oral lichen planus: a 6-year prospective follow-up study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80: 705-709.
15. Lu SY, Chen WJ, Eng HL. Response to levamisole and low-dose prednisolone in 41 patients with chronic oral ulcers: a 3-year open clinical trial and follow-up study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86:438-445.
16. Sun A, Chiang CP, Chiou PS, Wang JT, Liu BY, Wu YC. Immunomodulation by levamisole in patients with recurrent aphthous ulcers or oral lichen planus. J Oral Pathol Med 1994;23:172-177.
17. Sun A, Wang JT, Chia JS, Chiang CP. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus. Br J Dermatol 2005;152: 1187-1192.
18. Lewinski UH, Mavligit GM, Hersh EM. Cellular immune modulation after a single high dose of Levamisole in patients with carcinoma. Cancer 1980;46: 2185-2194.
19. Redondo JM, Lopez-Guerrero JA, Fresno M. Potentiation of interleukin-2 activity by levamisole and imidazole. Immunol Lett 1987;14:111-116.
20. Amery WK, Bruynseels JP. Levamisole, the story and the lessons. Int J Immunopharmacol 1992;14:481-486.
21. Janssen PA. The levamisole story. Prog Drug Res 1976;20: 347-383.
22. Cho NJ, Choi DY, Son SJ. Therapeutic effect of levamisole in recurrent aphthous stomatitis. Korean J Dermatol 1979; 17: 389-396.
23. Scheithauer W, Kornek GV, Marczell A, Karner J, Salem G, Greiner R, et al. Combined intravenous and intraperitoneal chemotherapy with fluorouracil+leucovorin vs fluorouracil+levamisole for adjuvant therapy of resected colon carcinoma. Br J Cancer 1998;77: 1349-1354.
24. Sany J. Immunological treatment of rheumatoid arthritis. Clin Exp Rheumatol 1990;8 Suppl 5:81-88.
25. Parsad D, Saini R, Negi KS. Comparison of combination of cimetidine and levamisole with cimetidine alone in the treatment of recalcitrant warts. Australas J Dermatol 1999; 40:93-95.
26. Amer M, Tosson Z, Soliman A, Selim AG, Salem A, al-Gendy AA. Verrucae treated by levamisole. Int J Dermatol 1991;30:738-740.
27. Agarwal S, Ramam M, Sharma VK, Khandpur S, Pal H, Pandey RM. A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo. Br J Dermatol 2005;153:163-166.
28. Pasricha JS, Khera V. Effect of prolonged treatment with levamisole on vitiligo with limited and slow-spreading disease. Int J Dermatol 1994;33:584-587.
29. Rovensky J, Cebecauer L, Zitnan D, Lukac J, Ferencik M. Levamisole treatment of systemic lupus erythematosus. Arthritis Rheum 1982;25:470-471.
30. Renoux G, Renoux M, Teller MN, McMahon S, Guillaumin JM. Potentiation of T-cell mediated immunity by levamisole. Clin Exp Immunol 1976;25:288-296.
31. Kim HK, Jung YB, Lee EW. Clinical application of D-penicil-lamine and levamisole in rheumatoid arthritis. J Korean Orthop Assoc 1983;18:81-88.
32. Rosenthal M, Trabert U, Muller W. The effect of levamisole on peripheral blood lymphocyte subpopulations in patients with rheumatoid arthritis and ankylosing spondylitis. Clin Exp Immunol 1976;25:493-496.
33. Sany J. A review of the effects of levamisole on erythrocyte sedimentation rate, acute phase proteins, and anemia. J Rheumatol Suppl 1978;4:43-47.
34. Scott J, Dieppe PA, Huskisson EC. Continuous and intermittent levamisole. A controlled trial. Ann Rheum Dis 1978; 37:259-261.